Pembrolizumab and Olaparib in Cervical Cancer Patients

Clinical trial NCT04483544 · TERMINATED

Trial details

NCT number: NCT04483544
Sponsor: Baptist Health South Florida
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Cervical Carcinoma

Start date: 2020-12-03
Primary completion: 2024-12-12
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.